氨己烯酸中国上市时间

Refractory complex partial epilepsy, also known as temporal lobe seizures and psychomotor seizures, presents with partial seizures accompanied by varying degrees of disturbance of consciousness. Epileptic discharges originate from the medial temporal lobe or frontal lobe. The origin, diffusion route and speed are different, and the clinical manifestations can vary greatly. Special sensory or simple autonomic nervous system symptoms are often auras. Attacks originating from deep structures, such as psychotic attacks (auras), may be short-lived and cause confusion in consciousness quickly; disorders of consciousness may also begin immediately, or even simply cause disturbances in consciousness. The main component of vigabatrin is vigabatrin (vigabatrin). The mechanism of action of vigabatrin is to irreversibly inhibit GABA aminotransferase (GABA-T) and increase the concentration of GABA in the brain. Indications are the treatment of epilepsy, especially partial seizures, in which other antiepileptic drugs are ineffective. Vigabatrin can also treat infantile spasms (West syndrome, West syndrome).

Time to market vigabatrin in China: Vigabatrin is not on the market in China. It is understood that Vigadrone is only available in a few countries, and Vigadrone produced by Sanofi in France is cost-effective. Its specifications are 500mg

Vigadrone is an oral medication that can be taken once or twice a day, before or after meals. It is advisable to drink half a glass of water when taking Vigadrone for treatment. If you have taken this drug for a sufficient period of time and your epilepsy does not improve, you should stop taking Vigadrone. At this time, Vigadrone should be gradually discontinued under the supervision of a doctor. The use of vigabatrin tablets and vigabatrin should be done under the guidance of an epilepsy expert or a child neurologist. Reactions after taking the medication should be reported to the doctor promptly.

Taking Vigadrone for treatment may affect your ability to drive and use machinery. Generally, patients with uncontrolled epilepsy are not allowed to drive or operate potentially dangerous machinery. Given reports of drowsiness during clinical use of Vigadrone, patients should be warned before initiating treatment with this product.

Note: The above information comes from the Internet and is compiled and edited by Medical Companion Travel (please correct me if there are any errors or omissions). It is only to provide information on the latest drugs on the market in the world and help Chinese patients understand the latest international new drug trends. It is only for internal discussion among medical staff and does not serve as any basis for medication. For specific medication guidelines, please consult the attending physician.

Recommended related articles: